Keisuke Goto

23PUBLICATIONS
62CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 01, 2026
Clinical and genomic characteristics of primary resistant disease to first-line immuno-oncology plus VEGFR inhibitor therapy in metastatic renal cell carcinoma.

|Sep 15, 2025
TUBB3 Is Associated With a Poor Prognosis and Basal Subtypes in Upper and Lower Tract Urothelial Carcinoma.

Naofumi Nomura, Yohei Sekino, Tetsutaro Hayashi

|Sep 15, 2025
Efficacy of Open-Ended Urinary Catheters in Preventing Catheter-Related Bladder Discomfort: A Randomized Controlled Trial.

Kohei Kobatake, Keisuke Goto, Tomoya Hatayama

|Sep 05, 2025
Long-Term Survival After Chemoradiotherapy for Renal Pelvis Cancer.

Yukinobu Shimada, Hiroyuki Kitano, Shunsuke Miyamoto

|Aug 11, 2025
Risk classification by pathological and biochemical prognostic factors determined by extensive exploration for metastatic hormone sensitive prostate cancer.

Keisuke Goto, Kohei Kobatake, Kenichiro Fukuoka

|Jul 18, 2025
Association Between Preoperative Penile Circumference and Urinary Function After Robot-Assisted Radical Prostatectomy.

Yuki Kohada, Hiroyuki Kitano, Shinsaku Tasaka

Pageof 4

Frequent Collaborators

15 joint publications

Nobuyuki Hinata

13 joint publications

Kohei Kobatake

10 joint publications

Yohei Sekino

5 joint publications

Tomoya Hatayama